Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-124519
Filing Date
2025-12-22
Accepted
2025-12-22 16:02:32
Documents
1
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 9481
  Complete submission text file 0001213900-25-124519.txt   10939
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address
Bodenstedt Matthias (Reporting) CIK: 0001920545 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39630 | Film No.: 251592399